PSYCHIATRIC DISORDERS: DEPRESSION, ANXIETY, AND PSYCHOSIS: A TEACHER’S COMPREHENSIVE GUIDE
Welcome, future pharmacists and healthcare professionals!
Psychiatric disorders refer to behavioral, emotional, or cognitive dysfunctions that are hard for a person to control and that are linked clinically to significant distress or impairment in social, occupational, or interpersonal functioning. These disorders affect millions of people worldwide and are among the most common causes of disability. As a pharmacy educator with years of experience teaching pharmacotherapeutics, I have observed that students often find psychiatric disorders challenging due to their complex pathophysiology and the stigma associated with mental illness. Let me tell you: Understanding psychiatric disorders is essential for every pharmacy professional.
In this comprehensive guide, I will walk you through the major psychiatric disorders—Depression, Anxiety, and Psychosis. I will explain their types, etiology, pathogenesis, clinical manifestations, and both non-pharmacological and pharmacological management. By the end of this article, you will have a thorough understanding of these critical conditions. Let us begin our journey!
Dpharmguru’s exam insights:
Psychiatric disorders are frequently tested in pharmacy exams. Remember: Depression is characterized by persistent sadness and loss of interest. Anxiety involves excessive fear and worry. Psychosis involves loss of contact with reality. Pay special attention to the pharmacological management of each condition—these are almost always asked in exams! Also, remember the difference between typical and atypical antipsychotics.
1. DEPRESSION
According to WHO, depression is a common mental disorder, characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and poor concentration.
Types of Depression
- Major Depressive Disorder (MDD): Most prevalent type. Constant depression, hopelessness, and loss of interest in previously enjoyable activities.
- Persistent Depressive Disorder (PDD): Formerly known as dysthymia. Milder but more chronic form of depression.
- Bipolar Disorder (BPD): Formerly known as manic-depressive disorder. Characterized by alternating episodes of hopelessness and mania.
- Seasonal Affective Disorder (SAD): Depression that happens during a specific period of the year, commonly in winter.
- Psychotic Depression: Severe depression along with psychosis (hallucinations or delusions).
- Postpartum Depression (PPD): Depression that develops following childbirth.
- Premenstrual Dysphoric Disorder (PMDD): Severe form of premenstrual syndrome with major mood swings prior to menstruation.
- Atypical Depression: Distinguished by mood reactivity—individuals’ moods can improve in response to happy circumstances.
Etiology of Depression
- Genetic Factors: Mutation in the gene responsible for encoding the serotonin transporter may account for genetic predisposition.
- Biochemical Factors: Deficiency of neurotransmitter amines (adrenaline, noradrenaline, serotonin, dopamine) in certain areas of the brain.
- Psychosocial Stress: Traumatic events such as death or loss of a loved one, financial problems, high stress, disease conditions, or childhood trauma.
- Hormones: Hormonal imbalances from pregnancy, postpartum, thyroid problems, menopause, or other conditions.
Pathogenesis of Depression
The exact mechanism has not yet been established, but monoaminergic systems of the brain are responsible for many behavioural symptoms. Functional deficiency of brain monoaminergic transmitters (adrenaline, dopamine, noradrenaline, serotonin) occurs in patients with depression.
Abnormal function may arise from:
- Altered synthesis, storage, or release of neurotransmitters
- Disturbed sensitivity of their receptors or sub-expression
Clinical Manifestations of Depression
- Feeling of sadness, tearfulness, emptiness, or hopelessness
- Outbursts of anger, irritability, or frustration
- Less interest or pleasure in normal activities
- Sleep disturbances (insomnia or sleeping too much)
- Lack of energy and tiredness
- Loss of appetite and weight loss, or increased appetite and weight gain
- Anxiety, agitation, or restlessness
- Slowed thinking, speaking, or body movements
- Feeling of worthlessness or guilt
- Difficulty in thinking, concentrating, making decisions, and remembering
- Physical problems (back pain or headaches)
- Frequent thoughts of death, suicide attempts, or committing suicide
Non-Pharmacological Management of Depression
- Cognitive Behavioural Therapy (CBT): Most studied psychotherapy for depression
- Electroconvulsive Therapy (ECT): Highly effective for severe depression, including medication-resistant depression
- Psychiatric Management: Establishing therapeutic alliance, psychiatric assessment, evaluating patient safety, monitoring psychiatric status, enhancing treatment adherence, providing education
Pharmacological Management of Depression
1. Monoamine Oxidase Inhibitors (MAOIs)
Phenelzine, Tranylcypromine—effective for atypical depression and treatment-resistant depression.
2. Tricyclic Antidepressants (TCAs)
- Noradrenaline and 5-HT Reuptake Inhibitors: Imipramine, Amitriptyline, Doxepin, Clomipramine, Nortriptyline
- Noradrenaline Reuptake Inhibitors: Amoxapine, Nortriptyline, Desipramine
3. Selective Serotonin Reuptake Inhibitors (SSRIs)
Fluoxetine, Escitalopram, Citalopram, Fluvoxamine, Sertraline
4. Atypical Antidepressants
Mianserin, Bupropion, Trazodone, Tianeptine
Dpharmguru’s exam insights:
Depression management is frequently tested. Remember: SSRIs (Fluoxetine, Sertraline) are first-line antidepressants. TCAs (Amitriptyline, Imipramine) are effective but have more side effects. MAOIs are used for atypical or treatment-resistant depression. A common exam question is: “What is the first-line treatment for depression?” (Answer: SSRIs).
2. ANXIETY
Anxiety is a feeling of fear, dread, and uneasiness (as a normal reaction to stress) that might make an individual sweat, feel restless, tense, and have a rapid heartbeat. But in patients with anxiety disorders, fear is not temporary and can be irresistible.
Types of Anxiety
- Panic Disorder: Sudden recurring panic attacks
- Phobia: Excessive fear of a specific object, situation, or activity
- Social Anxiety Disorder: Fear of being judged by others in social situations
- Obsessive-Compulsive Disorder (OCD): Recurring irrational thoughts causing specific behaviours repeatedly
- Separation Anxiety Disorder: Fear of being away from home or loved ones
- Illness Anxiety Disorder: Anxiety about personal health
- Post-traumatic Stress Disorder (PTSD): Anxiety after a traumatic event
Etiology of Anxiety
- Chemical Imbalance: Severe or long-term stress can change the chemical balance controlling mood
- Environmental Factors: Trauma might trigger an anxiety disorder
- Heredity: Anxiety disorders may be inherited from one or both parents
Pathogenesis of Anxiety
The exact mechanism of anxiety is not known. Several neurotransmitter systems are believed to have a role:
- Underactivation of the serotonergic system
- Overactivation of the noradrenergic system
- Disruption of the GABA system (response to benzodiazepine treatment)
- Corticosteroid regulation and its relationship to fear and anxiety symptoms
- Cholecystokinin as a neurotransmitter involved in regulating emotional states
Serotonin and GABA are inhibitory neurotransmitters that ease the stress response.
Clinical Manifestations of Anxiety
Physical Symptoms:
- Cold or sweaty hands
- Dry mouth
- Heart palpitations
- Nausea
- Numbness or tingling in hands or feet
- Muscle tension
- Breathlessness
Mental Symptoms:
- Feeling panic, fear, and uneasiness
- Nightmares
- Repeated memories of traumatic experiences
- Uncontrollable and obsessive thoughts
Behavioral Symptoms:
- Inability to be still and calm
- Repeated behaviors
- Difficulty in sleeping
Non-Pharmacological Management of Anxiety
- Sleeping enough
- Meditation
- Staying active and exercising
- Healthy diet
- Quitting alcohol, caffeine, and smoking
- Psychotherapy or counseling
- Cognitive Behavioural Therapy (CBT)
- Exposure therapy
Pharmacological Management of Anxiety
- Anti-anxiety Medications (Benzodiazepines): Clonazepam, Alprazolam, Lorazepam—decrease anxiety, panic, and worry (short-term use)
- Antidepressants: Imipramine, Diazepam—modify how the brain uses certain chemicals to improve mood and reduce stress
- Beta-blockers: Acebutolol, Bisoprolol, Carvedilol, Propranolol—reduce physical symptoms (rapid heartbeat, shaking, trembling)
Dpharmguru’s exam insights:
Anxiety management is frequently tested. Remember: Benzodiazepines (Alprazolam, Lorazepam) are used for short-term relief. SSRIs and SNRIs are first-line for long-term treatment. Beta-blockers can help with physical symptoms. A common exam question is: “What is the first-line treatment for generalized anxiety disorder?” (Answer: SSRIs or SNRIs).
3. PSYCHOSIS
Psychosis refers to loss of contact with reality, including delusions (false ideas) and hallucinations (seeing or hearing things that do not exist), thus affecting the way the brain processes information.
Types of Psychosis
- Bipolar Disorder: Manic episodes can lead to psychosis
- Brief Psychotic Disorder: Short and sudden onset in response to a stressful situation (usually lasts <30 days)
- Delusional Disorder: Inability to distinguish between what is real and imagined
- Drug-induced Psychosis: Occurs when withdrawing from alcohol or methamphetamine
- Postpartum Psychosis: Severe form of postpartum depression requiring emergency medical intervention
- Schizoaffective Disorder: Symptoms of a mood disorder and schizophrenia
- Schizophrenia: Characterized by a range of psychotic symptoms
- Schizophreniform Disorder: Short-term schizophrenia
- Severe Depression: Can cause psychosis symptoms
Etiology of Psychosis
- Alcohol and methamphetamine
- Brain cysts or tumours
- Certain prescription drugs (steroids and stimulants)
- Certain types of epilepsy
- Dementia
- HIV
- Parkinsonism
- Stroke
- Schizophrenia, schizoaffective disorder, bipolar disorder, or depression
- Family history of psychosis
Pathogenesis of Psychosis
Psychosis involves dysregulation of dopamine and other neurotransmitter systems in the brain. The dopamine hypothesis suggests that excess dopaminergic activity in certain brain regions (mesolimbic pathway) leads to positive symptoms (hallucinations, delusions), while reduced dopaminergic activity in other regions (mesocortical pathway) leads to negative symptoms (apathy, social withdrawal).
Clinical Manifestations of Psychosis
- Delusions: False beliefs not based in reality
- Hallucinations: Seeing or hearing things that do not exist
- Disorganized thinking and speech
- Thoughts changing from one topic to another
Non-Pharmacological Management of Psychosis
- Changing the environment
- Emphasizing caregiver and family participation
- Maintaining predictable routines
- Diffusing restlessness with tasks
- Exercising
- Listening to music
- Psychotherapy
- Friends and family support
- Identifying and removing triggers
- Recruiting a loved one to watch for signs
Pharmacological Management of Psychosis
Typical (First-Generation) Antipsychotics
- Haloperidol
- Loxapine
- Thiothixene
- Fluphenazine
- Trifluoperazine
- Chlorpromazine
- Perphenazine
Atypical (Second-Generation) Antipsychotics
- Aripiprazole
- Clozapine
- Iloperidone
- Ziprasidone
- Paliperidone
- Lurasidone
- Brexipiprazole
- Risperidone
- Asenapine maleate
- Quetiapine
- Cariprazine
- Olanzapine
Dpharmguru’s exam insights:
Psychosis management is frequently tested. Remember: Typical antipsychotics (Haloperidol, Chlorpromazine) have higher risk of extrapyramidal side effects. Atypical antipsychotics (Risperidone, Olanzapine, Quetiapine) have lower risk of movement disorders but may cause metabolic side effects. Clozapine is used for treatment-resistant schizophrenia. A common exam question is: “What is the difference between typical and atypical antipsychotics?” (Answer: Typical antipsychotics have higher risk of extrapyramidal side effects; atypical antipsychotics have lower risk of movement disorders).
COMPARISON: PSYCHIATRIC DISORDERS
| Feature | Depression | Anxiety | Psychosis |
|---|---|---|---|
| Key Feature | Persistent sadness, loss of interest | Excessive fear, worry | Loss of contact with reality |
| Neurotransmitter | Serotonin, Noradrenaline deficiency | Serotonin, GABA, Noradrenaline dysregulation | Dopamine excess |
| First-Line Treatment | SSRIs (Fluoxetine, Sertraline) | SSRIs, SNRIs, Benzodiazepines | Atypical Antipsychotics |
FREQUENTLY ASKED QUESTIONS (FAQs)
1. What is the difference between depression and sadness?
Sadness is a normal emotional response to specific events and is temporary. Depression is a clinical condition with persistent symptoms lasting at least two weeks, affecting daily functioning.
2. What is the first-line treatment for depression?
First-line treatment for depression is Selective Serotonin Reuptake Inhibitors (SSRIs) such as Fluoxetine, Sertraline, and Escitalopram.
3. What is the difference between typical and atypical antipsychotics?
Typical antipsychotics (first-generation) have a higher risk of extrapyramidal side effects (movement disorders). Atypical antipsychotics (second-generation) have a lower risk of movement disorders but may cause metabolic side effects (weight gain, diabetes).
4. What is the difference between anxiety and anxiety disorder?
Anxiety is a normal reaction to stress that is temporary. Anxiety disorder involves excessive, persistent fear or worry that interferes with daily functioning.
5. What is the dopamine hypothesis of psychosis?
The dopamine hypothesis suggests that psychosis results from excess dopaminergic activity in certain brain regions (mesolimbic pathway) leading to positive symptoms (hallucinations, delusions), while reduced activity in other regions (mesocortical pathway) leads to negative symptoms.
6. What are the side effects of antipsychotics?
Side effects include extrapyramidal symptoms (tremors, rigidity, tardive dyskinesia) with typical antipsychotics, and metabolic side effects (weight gain, diabetes, hyperlipidemia) with atypical antipsychotics.
SUMMARY
Psychiatric disorders are among the most common and disabling conditions affecting people worldwide. This guide covered the major psychiatric disorders:
- Depression: Persistent sadness and loss of interest. Managed with SSRIs, TCAs, MAOIs, and psychotherapy.
- Anxiety: Excessive fear and worry. Managed with SSRIs, SNRIs, Benzodiazepines, and CBT.
- Psychosis: Loss of contact with reality. Managed with typical and atypical antipsychotics.
As I always tell my students: “Psychiatric disorders are medical conditions, not character flaws. Understanding their pathophysiology and pharmacology is essential for reducing stigma and improving patient outcomes.”
REFERENCES AND FURTHER READING
- Pharmacy Council of India (PCI). (2022). Pharmacotherapeutics Syllabus. New Delhi: PCI.
- Rang, H. P., & Dale, M. M. (2021). Rang & Dale’s Pharmacology (9th ed.). Elsevier.
- Goodman, L. S., & Gilman, A. (2018). Goodman & Gilman’s The Pharmacological Basis of Therapeutics (13th ed.). McGraw-Hill.
- Katzung, B. G. (2021). Basic and Clinical Pharmacology (15th ed.). McGraw-Hill.
- American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders (5th ed.).
- World Health Organization (WHO). (2022). Mental Disorders. Retrieved from https://www.who.int.
Disclaimer: This article is for educational purposes only and does not constitute medical advice. Always consult qualified healthcare professionals for medical concerns. Pharmaceutical regulations and guidelines may vary by region—always refer to your local regulatory authorities for specific requirements.
written by:
Dr. N. Sujith Kumar
For More Study Materials, Visit: www.dpharmguru.com
